-transparent.png){kind=logo}
We studied the pharmacokinetics of amikacin in a patient with acute oliguric renal failure during continuous veno-venous hemofiltration (CVVH). The volume of distribution, terminal disposition rate constant and elimination half-life for amikacin were 27.9 L, 0.023.h-1 and 29.7 h, respectively. Total body clearance for amikacin was 10.54 ml/min and CVVH clearance was 10.11 ml/min. Sieving coefficient for amikacin was 0.93 +/- 0.16. Our data show that during CVVH at a filtration rate of 10 ml/min, the clearance of amikacin is similar to that reported in patients with renal failure who are not being treated with CVVH.
Related Publications
E Armendariz, and
L Chelluri, and
R Ptachcinski
April 1991,
Critical care medicine,
E Armendariz, and
L Chelluri, and
R Ptachcinski
December 2013,
Infectious diseases and therapy,
E Armendariz, and
L Chelluri, and
R Ptachcinski
February 2001,
Intensive care medicine,
E Armendariz, and
L Chelluri, and
R Ptachcinski
February 2003,
Zhongguo wei zhong bing ji jiu yi xue = Chinese critical care medicine = Zhongguo weizhongbing jijiuyixue,
E Armendariz, and
L Chelluri, and
R Ptachcinski
December 1991,
Nihon rinsho. Japanese journal of clinical medicine,
E Armendariz, and
L Chelluri, and
R Ptachcinski
December 1996,
Journal of clinical pharmacology,
E Armendariz, and
L Chelluri, and
R Ptachcinski
March 2018,
Military medicine,
E Armendariz, and
L Chelluri, and
R Ptachcinski
April 2010,
International journal of clinical pharmacology and therapeutics,
E Armendariz, and
L Chelluri, and
R Ptachcinski
October 2008,
Intensive care medicine,
E Armendariz, and
L Chelluri, and
R Ptachcinski
January 1998,
ASAIO journal (American Society for Artificial Internal Organs : 1992),
